# Capricor Therapeutics, Inc.

- **Section**: news
- **Answer**: Capricor Therapeutics, Inc.: 27 headlines on record, 14 headlines in the last 90 days. Its story counts 3 milestones.
- **As of**: 2026-11-17
- **Cite**: Capricor Therapeutics, Inc., News. Alion, Nov 17, 2026. https://alion.io/company/capricor/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 1824782
- **Name**: Capricor Therapeutics, Inc.
- **Domain**: capricor.com
- **Url**: <https://alion.io/company/capricor>

## Figures

- Label: Headlines; Value: 27
- Label: In 90 days; Value: 14
- Label: Milestones; Value: 3

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 26
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 3

## News

- [Capricor Therapeutics (CAPR) Stock Surges on Extended Duchenne Treatment Data](https://blockonomi.com/capricor-therapeutics-capr-stock-surges-on-extended-duchenne-treatment-data/) — Date: 2026-09-30; Kind: News; Source: Blockonomi
- [Capricor (CAPR) Stock Jumps as Duchenne Drug Clears Key Data Hurdle](https://coincentral.com/capricor-capr-stock-jumps-as-duchenne-drug-clears-key-data-hurdle/) — Date: 2026-09-30; Kind: News; Source: CoinCentral
- [Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Capricor Therapeutics (CAPR)](https://theglobeandmail.com/investing/markets/stocks/CAPR/pressreleases/4848443/analysts-offer-insights-on-healthcare-companies-irhythm-technologies-irtc-and-capricor-therapeutics-capr/) — Date: 2026-09-29; Kind: Press release; Source: The Globe and Mail
- [Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026](https://newmediawire.com/news/kaplan-fox-urges-capricor-therapeutics-inc-nasdaq-capr-investors-to-contact-the-firm-before-the-deadline-on-september-28-2026-7090081) — Date: 2026-09-25; Kind: News; Source: NewMediaWire
- [Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Lead Plaintiff Deadline is September 28, 2026](https://newmediawire.com/news/kaplan-fox-announces-a-securities-class-action-filed-against-capricor-therapeutics-inc-nasdaq-capr-lead-plaintiff-deadline-is-september-28-2026-7090038) — Date: 2026-09-24; Kind: News; Source: NewMediaWire
- [SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR](https://prnewswire.com/news-releases/suewallst-reminds-capricor-therapeutics-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-28-2026---capr-302888725.html) — Date: 2026-09-24; Kind: Press release; Source: PRNewswire
- [Capricor Therapeutics (CAPR) Stock Gets Fair Value Boost After Deramiocel Analyst Revisions](https://finance.yahoo.com/healthcare/articles/capricor-therapeutics-capr-stock-gets-131904781.html) — Date: 2026-09-23; Kind: News; Source: YahooFinance
- [CAPR Class Action: Capricor Therapeutics Investors are Notified of the Upcoming September 28 Deadline in Ongoing Securities Fraud Class Action over Clinical Data](https://prnewswire.com/news-releases/capr-class-action-capricor-therapeutics-investors-are-notified-of-the-upcoming-september-28-deadline-in-ongoing-securities-fraud-class-action-over-clinical-data-302885424.html) — Date: 2026-09-22; Kind: Press release; Source: PRNewswire
- [Capricor Therapeutics, Inc. Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending September 28, 2026 Lead Plaintiff Deadline](https://prnewswire.com/news-releases/capricor-therapeutics-inc-stockholders-with-significant-losses-should-contact-robbins-llp-before-the-pending-september-28-2026-lead-plaintiff-deadline-302883636.html) — Date: 2026-09-19; Kind: Press release; Source: PRNewswire
- [Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress](https://finance.yahoo.com/healthcare/articles/capricor-therapeutics-present-hope-3-123000831.html) — Date: 2026-09-17; Kind: News; Source: YahooFinance
- [CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt - AOL](https://aol.com/articles/capr-investor-alert-capricor-therapeutics-141100000.html) — Date: 2026-09-03; Kind: News; Source: AOL.com
- [CAPR Class Action Alert: Capricor Therapeutics Clinical Data Issues and Subsequent 64% Stock Drop Lead to Investor Securities Fraud Class Action to Recover Losses](https://morningstar.com/news/pr-newswire/20260901ny37313/capr-class-action-alert-capricor-therapeutics-clinical-data-issues-and-subsequent-64-stock-drop-lead-to-investor-securities-fraud-class-action-to-recover-losses) — Date: 2026-09-01; Kind: Press release; Source: morningstar.com
- [Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA](https://capricor.com/investors/news-events/press-releases/detail/354/capricor-therapeutics-announces-extension-of-pdufa-target) — Date: 2026-08-24; Kind: Press release
- [Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update](https://capricor.com/investors/news-events/press-releases/detail/353/capricor-therapeutics-reports-second-quarter-2026-financial) — Date: 2026-08-13; Kind: Press release
- [Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13](https://capricor.com/investors/news-events/press-releases/detail/352/capricor-therapeutics-to-report-second-quarter-2026) — Date: 2026-08-10; Kind: Press release
- [Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel](https://capricor.com/investors/news-events/press-releases/detail/351/capricor-therapeutics-provides-update-on-fda-advisory) — Date: 2026-07-30; Kind: Press release
- [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics' Deramiocel in Duchenne Muscular Dystrophy](https://capricor.com/investors/news-events/press-releases/detail/350/the-lancet-publishes-hope-3-data-for-capricor) — Date: 2026-07-29; Kind: Press release
- [Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel](https://capricor.com/investors/news-events/press-releases/detail/349/capricor-comments-on-briefing-materials-ahead-of-july-29) — Date: 2026-07-27; Kind: Press release
- [Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy](https://capricor.com/investors/news-events/press-releases/detail/348/capricor-therapeutics-announces-fda-advisory-committee) — Date: 2026-06-26; Kind: Press release
- [Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference](https://capricor.com/investors/news-events/press-releases/detail/347/capricor-to-present-positive-five-year-hope-2-ole-data-and) — Date: 2026-06-26; Kind: Press release
- [Capricor Therapeutics to Present at Upcoming Investor Conferences](https://capricor.com/investors/news-events/press-releases/detail/346/capricor-therapeutics-to-present-at-upcoming-investor) — Date: 2026-06-08; Kind: Press release
- [INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Securities Fraud Class Action Lawsuit Filed; September 28, 2026, Lead Plaintiff Deadline](https://theglobeandmail.com/investing/markets/markets-news/NewMediaWire/3994413/investor-alert-capricor-therapeutics-inc-capr-securities-fraud-class-action-lawsuit-filed-september-28-2026-lead-plaintiff-deadline/) — Date: 2025-12-16; Kind: News; Source: The Globe and Mail
- [What Does the Market Think About Capricor Therapeutics Inc?](https://benzinga.com/insights/short-sellers/25/12/49311683/what-does-the-market-think-about-capricor-therapeutics-inc) — Date: 2025-12-10; Kind: News; Source: benzinga.com
- [Decoding Capricor Therapeutics's Options Activity: What's the Big Picture?](https://nasdaq.com/articles/decoding-capricor-therapeuticss-options-activity-whats-big-picture) — Date: 2025-06-15; Kind: News; Source: Nasdaq
- [Decoding 12 Analyst Evaluations For Capricor Therapeutics](https://nasdaq.com/articles/decoding-12-analyst-evaluations-capricor-therapeutics) — Date: 2024-11-13; Kind: News; Source: Nasdaq
- [HOPE-3 Phase 3 dataset](https://thelancet.com/journals/lancet/article/PIIS0140-6736(26)01385-1/fulltext) — Kind: News; Source: thelancet.com

## Story

- **Went public NASDAQ: CAPR**
- **Founded**
- [Won a grant $1.7M · CORDIS](https://www.sbir.gov/awards?keywords=1UT2HL131226-01)

---
[Page](https://alion.io/company/capricor/news) · [JSON](https://alion.io/company/capricor/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
